Riociguat improves health-related quality of life for patients with pulmonary arterial hypertension: results from the phase 4 MOTION study

by Namita Sood, Alvaro Aranda, David Platt, Anneliese LaRose, Frank Kleinjung, Gerald O’Brien
Published 2019-02-01

Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a...

by Fernando J. Martinez, Brian J. Lipworth, Klaus F. Rabe, David J. Collier, Gary T. Ferguson, Sanjay Sethi, Gregory J. Feldman, Gerald O’Brien, Martin Jenkins, Colin Reisner
Published 2020-05-01

Validation of a claims-based algorithm to identify patients with chronic thromboembolic pulmonary hypertension using electronic health record data

by Simon Teal, William R. Auger, Rodney J. Hughes, Dena Rosen Ramey, Kelly S. Lewis, Gerald O'Brien, Avin Yaldo, Tanya M. Burton, Tim Bancroft, Jerry Seare, Joerg Fabian
Published 2018-12-01